SubHero Banner
Text

May 2018

Core topics in this month’s edition include:

  • Aimovig (erenumab-aooe) – new drug approval
  • Andexxa (coagulation factor Xa [recombinant], inactivated-zhzo) – new orphan drug approval
  • Palynziq (pegvaliase-pqpz) – new drug approval
  • Retacrit (epoetin alfa-epbx) – new biosimilar approval

Download PDF

Text